Citigroup’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-508,700
Closed -$19.9M 7583
2018
Q1
$19.9M Buy
508,700
+502,600
+8,239% +$18.4M 0.02% 780
2017
Q4
$199K Buy
6,100
+5,800
+1,933% +$201K ﹤0.01% 5043
2017
Q3
$14K Hold
300
﹤0.01% 6575
2017
Q2
$15K Buy
+300
New +$13.3K ﹤0.01% 6376
2017
Q1
Sell
-100
Closed -$3K 7166
2016
Q4
$3K Sell
100
-500
-83% -$19.4K ﹤0.01% 7006
2016
Q3
$30K Buy
+600
New +$31.3K ﹤0.01% 5977

Other funds holding ACHC

Citigroup's ACHC Position: Q1 2026 in Review

Citigroup reduced its Acadia Healthcare (ACHC) stake by 8.6% in Q1 2026, selling an estimated $4.03M and leaving 2,352,318 shares worth $55M. The position accounts for 0.02% of the portfolio, ranked #608.

Citigroup first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $72M in Q1 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Citigroup held 2,352,318 shares of Acadia Healthcare worth $55M as of Q1 2026.
  • Citigroup sold 222,622 Acadia Healthcare shares in Q1 2026, an estimated $4.03M.
  • Acadia Healthcare made up 0.02% of Citigroup's portfolio in Q1 2026, its #608 holding.
  • Citigroup first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Acadia Healthcare position peaked at $72M in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.